Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IL6ST | P40189 | 5/20 | 0.68 |
| ▸ | STAT3 | P40763 | 1/20 | 0.59 |
| ▸ | PIK3CD | O00329 | 1/20 | 0.39 |
| ▸ | IDH1 | O75874 | 5/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18384326 | 1.00 | IL6ST (0.68) | IL6STSTAT3PIK3CDIDH1 | |
| SCHEMBL18391412 | 1.00 | IL6ST (0.68) | IL6STSTAT3PIK3CDIDH1 | |
| SCHEMBL18384293 | 1.00 | IL6ST (0.68) | IL6STSTAT3PIK3CDIDH1 | |
| SCHEMBL21153766 | 0.78 | IL6ST (0.67) | IL6STSTAT3PIK3CDIDH1 | |
| SCHEMBL21154125 | 0.78 | IL6ST (0.67) | IL6STSTAT3PIK3CDIDH1 | |
| SCHEMBL3768819 | 0.76 | IL6ST (0.56) | IL6STSTAT3PIK3CDIDH1 | |
| SCHEMBL7531951 | 0.76 | IL6ST (0.56) | IL6STSTAT3PIK3CDIDH1 | |
| SCHEMBL15448141 | 0.76 | IL6ST (0.50) | IL6STSTAT3PIK3CDIDH1 | |
| SCHEMBL18562134 | 0.76 | IL6ST (0.50) | IL6STSTAT3PIK3CDIDH1 | |
| SCHEMBL15448064 | 0.76 | IL6ST (0.50) | IL6STSTAT3PIK3CDIDH1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10472395-B2 | Cyclic peptide analogs and conjugates thereof | SIRENAS LLC (US) | 2019-11-12 | — | — | US | disclosed |
| US-20170015710-A1 | CYCLIC PEPTIDE ANALOGS AND CONJUGATES THEREOF | SIRENAS LLC (US) | 2017-01-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170015710-A1 | CYCLIC PEPTIDE ANALOGS AND CONJUGATES THEREOF | VIP, NGLY1, GRPR | IL6ST 1287/4885STAT3 2624/4885PIK3CD 2476/4885 |
| US-10472395-B2 | Cyclic peptide analogs and conjugates thereof | VIP, NGLY1, GRPR | IL6ST 1287/4885STAT3 2624/4885PIK3CD 2476/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.